Copyright © Inderes 2011 - present. All rights reserved.

Nolato

59.2

 

SEK

 

-2.23 %

Less than 1K followers

NOLA B

NASDAQ Stockholm

Industrial Goods & Services

Industrials

-2.23%
+9.12%
-3.19%
+9.23%
+9.73%
-1.99%
-3.11%
-6.92%
+4,893.38%

Nolato operates in the manufacturing industry and focuses on the development, manufacture and distribution of plastic components and systems for various industries. The company's products are used in sectors such as the automotive industry, medical technology and consumer electronics. The business is global with a main presence in Europe, North America and Asia. Nolato was founded in 1938 and is headquartered in Torekov, Sweden.

Read more
Market cap
15.95B SEK
Turnover
27.87M SEK
Revenue
9.66B
EBIT %
9.45 %
P/E
24.26
Dividend yield-%
2.53 %
Financial calendar
18/7
2025

Interim report Q2'25

28/10
2025

Interim report Q3'25

5/2
2026

Annual report '25

ShowingAll content types
Third party research

Nolato: Impressive margin lift - ABG

Impressive margin lift in both segments, EBITA +6% vs. cons We raise EBITA by 4-1%, of which -1pp from FX 16-14x '25e-'26e EV/EBITA, 60% of EBITA non-cyclical Medical Impressive margin lift in both segments Nolato reported Q1 sales 2% below Modular Finance...

Nolato

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research

Nolato: Bigger margin lift than expected - ABG

EBITA SEK 271m (+3% vs. ABG, +6% vs. IR cons) We expect cons EBITA upgrades of 3-4% for '25e 15-13x '25e-'26e EV/EBITA on pre-Q1 estimates Q1 outcome Sales came in at SEK 2,453m (-3% vs. ABG SEK 2,527m, -2% vs. Modular Finance IR cons SEK 2,494m), up...

Nolato
Third party research

Nolato: Resilient Medical exposure in a chaotic market - ABG

Q1e: a solid quarter with EBITA up 11% y-o-y Higher estimates following ambitious new targets Medical (~60% of EBITA) should be resilient in a downturn Q1e: a solid quarter with EBITA up 11% y-o-y We expect Nolato to report Q1 net sales of SEK 2,527m...

Nolato
Third party research

Nolato: CMD recap: back to earnings growth focus - ABG

>12% EBITA margin target looks doable... ...more uncertainty on the 8% org. growth target, in our view Back to earnings growth focus after a couple years of putting out fires >12% EBITA margin target looks doable... On its Capital Markets Day today, ...

Nolato
Third party research

Nolato: New targets ahead of CMD - ABG

New targets: >8% org. growth, >12% EBITA margin, >15% ROCE Growth and margin targets imply 15%/12% upside to '26e ABGe/IR cons CMD at 13:00 CET, webcast link here New targets presented ahead of CMD Nolato presents new financial targets ahead of its Capital...

Nolato
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.